B7-1 inhibitors (Wyeth)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameB7-1 inhibitors (Wyeth)

Drug Alias Nameimmunosuppressant (B7-1) (Wyeth)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitorsCluster of differentiation 80 inhibitorsT-cell-specific surface glycoprotein CD28 inhibitors

TargetsCluster of differentiation 80Cytotoxic T-Lymphocyte-Associated Antigen 4T-cell-specific surface glycoprotein CD28

Therapy Area/IndicationsRejection of organ transplantationAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesWyeth Research

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesWyeth Research

Active IndicationsN/A

Inactive IndicationsRejection of organ transplantationAutoimmune Diseases

Other Information

ATC CodeN/A